Journals / Bitlis Eren Üniversitesi Fen Bilimleri Dergisi / 2020 / Cilt: 9 - Sayı: 2

The Synthesis, Characterization and Molecular Docking Studies of Novel 1,2,3-Triazole Derivatives as Xanthine Oxidase Inhibitor

Ksantin Oksidaz İnhibitörü Yeni 1,2,3-Triazol Türevlerinin Sentezi, Karakterizasyonu ve Moleküler Doking Çalışmaları

Pages
644–654
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Finally, the binding modes of compounds 4 and 5 in the active part of xanthine oxidase (PDB ID:3NVY) were explained by molecular docking studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, the synthesis, characterization of novel 1,2,3-triazole compounds (4 and 5), investigation of their in vitro inhibition effects on xanthine oxidase and molecular docking studies were carried out.
📊
Key Findings & Data:For this purpose, firstly; the target products (4 and 5) were synthesized by various chemical transformations starting from butadiene sulfone.
💡
Conclusion & Impact:Finally, the binding modes of compounds 4 and 5 in the active part of xanthine oxidase (PDB ID:3NVY) were explained by molecular docking studies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this study, the synthesis, characterization of novel 1,2,3-triazole compounds (4 and 5), investigation of their in vitro inhibition effects on xanthine oxidase and molecular docking studies were carried out. For this purpose, firstly; the target products (4 and 5) were synthesized by various chemical transformations starting from butadiene sulfone. All of the synthesized compounds were characterized by spectroscopic methods. In the second step; in vitro inhibition effects of compounds 4 and 5 on xanthine oxidase were investigated. According to the enzyme inhibition results, It was determined that compounds 4 (IC50 = 0.609 µM) and 5 (IC50 = 0.901 µM) showed stronger inhibition effect than allopurinol (IC50 = 1.143 µM), which is used as a drug for inhibition of xanthine oxidase. Finally, the binding modes of compounds 4 and 5 in the active part of xanthine oxidase (PDB ID:3NVY) were explained by molecular docking studies.

Özet

Bu çalışmada, yeni 1,2,3-triazol bileşiklerinin (4 ve 5) sentezi, karakterizasyonu, ksantin oksidaz enzimi üzerinein vitro inhibisyon etkilerinin incelenmesi ve moleküler doking çalışmaları gerçekleştirildi. Bu amaçla öncelikle;hedef ürünler (4 ve 5), bütadien sülfondan çıkılarak çeşitli kimyasal transformasyonlarla sentezlendi. Sentezlenenbütün bileşiklerin yapıları spektroskopik yöntemlerle aydınlatıldı. İkinci aşamada; 4 ve 5 bileşiklerinin ksantinoksidaz enzimi üzerine in vitro inhibisyon etkileri incelendi. Enzim inhibisyon sonuçlarına göre 4 (IC50 = 0.609µM) ve 5 (IC50 = 0.901 µM) bileşiklerinin, ksantin oksidaz enzim inhibisyonu için ilaç olarak kullanılanallopurinolden (IC50 = 1.143 µM) daha güçlü inhibisyon etki gösterdiği tespit edildi. Son olarak; 4 ve 5bileşiklerinin, ksantin oksidaz eziminin (PDB ID:3NVY) aktif kısmına bağlanma modları, moleküler dokingçalışmaları ile açıklandı.

🔖

Cite This Article

TAN, A. (2022). The Synthesis, Characterization and Molecular Docking Studies of Novel 1,2,3-Triazole Derivatives as Xanthine Oxidase Inhibitor. Bitlis Eren Üniversitesi Fen Bilimleri Dergisi, Cilt: 9 - Sayı: 2, 644–654. https://ajindex.com/articles/466742

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Mehta S.K., Nayeem N. 2014. Natural xanthine oxidase inhibitors for management of gout: a review. Research and reviews: journal of medical and health sciences, 3: 4-13
  2. Borges F., Fernandes E., Roleira F. 2002. Progress towards the discovery of xanthine oxidase inhibitors. Current medicinal chemistry, 9: 195-217
  3. Kıbrız İ.E., Saçmacı M., Yıldırım İ., Abbas Ali Noma S., Taşkın T.T., Ateş B. 2018. Xanthine oxidase inhibitory activity of new pyrrole carboxamide derivatives: In vitro and in silico studies. Archiv der pharmazie, 351 (10): 1800165
  4. Pacher P., Nivorozhkin A., Szabo C. 2006. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacological reviews, 58: 87- 114
  5. Baldwin J., Kasinger P., Novello F., Sprague J., Duggan D. 1975. 4-trifluoromethylimidazoles and 5-(4-pyridyl)-1, 2, 4-triazoles, new classes of xanthine oxidase inhibitors. Journal of medicinal chemistry, 18: 895-900
  6. Wang S., Yan J., Wang J., Chen J., Zhang T., Zhao Y., Xue M. 2010. Synthesis of some 5- phenylisoxazole-3-carboxylic acid derivatives as potent xanthine oxidase inhibitors. European journal of medicinal chemistry, 45: 2663-2670
  7. Ishibuchi S., Morimoto H., Oe T., Ikebe T., Inoue H., Fukunari A., Kamezawa M., Yamada I., Naka Y. 2001. Synthesis and structure–activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors. Bioorganic & medicinal chemistry letters, 11: 879-882
  8. Shukla S., Kumar D., Ojha R., Gupta M.K., Nepali K., Bedi P.M. 2014. 4, 6‐ diaryl/heteroarylpyrimidin‐2 (1h)‐ones as a new class of xanthine oxidase inhibitors. Archiv der pharmazie, 347: 486-495
  9. Song J.U., Choi S.P., Kim T.H., Jung C.-K., Lee J.-Y., Jung S.-H., Kim G.T. 2015. Design and synthesis of novel 2-(indol-5-yl) thiazole derivatives as xanthine oxidase inhibitors. Bioorganic & medicinal chemistry letters, 25: 1254-1258
  10. Phatak P.S., Bakale R.D., Dhumal S.T., Dahiwade L.K., Choudhari P.B., Krishna V.S., Sriram D., Haval K.P. 2019. Synthesis, antitubercular evaluation and molecular docking studies of phthalimide bearing 1,2,3-triazoles. Synthetic communications, 49: 2017-2028
  11. Rajasekar S., Anbarasan P. 2019. A general proline catalyzed synthesis of 4, 5‐disubstituted n‐ sulfonyl‐1, 2, 3‐triazoles from 1, 3‐dicarbonyl compounds and sulfonyl azide. Chemistry-an asian journal,
  12. Kushwaha K., Kaushik N., Jain S.C. 2014. Design and synthesis